56980-14-4 Usage
Description
5-Methoxy-2-(4-MethoxyphenylaMino)benzoic acid is an organic compound characterized by its unique chemical structure, which features a benzoic acid backbone with methoxy and amino substituents. This molecule exhibits a range of properties that make it suitable for various applications in the pharmaceutical and chemical industries.
Uses
Used in Pharmaceutical Industry:
5-Methoxy-2-(4-MethoxyphenylaMino)benzoic acid is used as an intermediate in the synthesis of more complex pharmaceutical compounds. Its unique structure allows for the creation of a variety of biologically active molecules with potential therapeutic applications.
Used in Chemical Industry:
5-Methoxy-2-(4-MethoxyphenylaMino)benzoic acid is used as a building block for the construction of photoswitchable macrocycles incorporating acridane moieties. These macrocycles have potential applications in various fields, including materials science and molecular electronics, due to their ability to undergo reversible photochemical reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 56980-14-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,9,8 and 0 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 56980-14:
(7*5)+(6*6)+(5*9)+(4*8)+(3*0)+(2*1)+(1*4)=154
154 % 10 = 4
So 56980-14-4 is a valid CAS Registry Number.
InChI:InChI=1/C15H15NO4/c1-19-11-5-3-10(4-6-11)16-14-8-7-12(20-2)9-13(14)15(17)18/h3-9,16H,1-2H3,(H,17,18)
56980-14-4Relevant articles and documents
Antitumor compound, synthesis method and applications thereof
-
Paragraph 0136-0140, (2020/05/01)
The invention belongs to the field of medicinal chemistry, and particularly relates to an antitumor compound, a synthesis method and applications thereof, wherein the compound has a structure represented by a general formula I or a general formula II, and
ACRIDINES AS INHIBITORS OF HASPIN AND DYRK KINASES
-
Page/Page column 28; 29; 32, (2011/10/31)
The present disclosure is directed to compounds of Formula I: which are inhibitors of Haspin kinase and DYRK kinases. The compounds of the present disclosure, and compositions thereof, are useful in the treatment of disease related to Haspin kinase and DY
Photoswitchable macrocycles incorporating acridane moieties
Orda-Zgadzaj, Marzena,Abraham, Werner
, p. 3345 - 3356 (2008/09/21)
Novel crown ethers incorporating one to three 9-phenyl-acridinium units were synthesized in moderate yields. The acridinium units within the macrocycles were converted into the photoactive N-methyl-9-methoxy-9-phenyl-9,10- dihydroacridine (N-methyl-9-methoxy-9-phenylacridane) units. Georg Thieme Verlag Stuttgart.
